Standard Life Aberdeen »

Eloxx Pharmaceuticals shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Eloxx Pharmaceuticals shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Eloxx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eloxx Pharmaceuticals held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eloxx Pharmaceuticals by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 400k 13.88

More positions owned by Standard Life Aberdeen

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Cisco Systems (CSCO)
Johnson & Johnson (JNJ)

View all positions for Standard Life Aberdeen

Top funds holding Eloxx Pharmaceuticals

Stonepine Capital Management
Nantahala Capital Management
Standard Life Aberdeen
Samsara BioCapital
Vanguard Capital Management
Vanguard Fiduciary Trust
Vanguard Global Advisers
Wells Fargo & Company
Pioneer Family Office
Altshuler Shaham
Barclays
Old Point Trust & Financial Services N A
Activest Wealth Management

View all funds holding Eloxx Pharmaceuticals